Charles River Laboratories International (CRL) Invested Capital (2009 - 2026)

Charles River Laboratories International has reported Invested Capital for 18 years, with the latest figure at $5.5 billion in Q2 2026.

• On a quarterly basis, Invested Capital fell 3.97% year-over-year to $5.5 billion in Q2 2026; TTM through Jun 2026 was $5.5 billion, a 3.97% decrease from a year earlier, with the FY2025 full-year figure at $5.3 billion, down 7.02% from the prior year.
• Invested Capital was $5.5 billion for Q2 2026 at Charles River Laboratories International, down from $5.6 billion in the prior quarter.
• The five-year high for Invested Capital was $6.3 billion in Q1 2024, with the low at $5.3 billion in Q1 2022.
• Average Invested Capital over 5 years is $5.8 billion, with a median of $5.7 billion recorded in 2024.
• The sharpest annual moves came in 2022 and 2025: Invested Capital advanced 20.49% in 2022, then decreased 9.45% in 2025.
• Over 5 years, Invested Capital stood at $5.7 billion in 2022, then gained by 9.86% to $6.2 billion in 2023, then declined by 8.68% to $5.7 billion in 2024, then dropped by 7.02% to $5.3 billion in 2025, then grew by 3.01% to $5.5 billion in 2026.
• The last three Invested Capital figures came in at $5.5 billion (Q2 2026), $5.6 billion (Q1 2026), and $5.3 billion (Q4 2025), per Business Quant data.